Cardea SOLO operates on a buy and bill model, which means you pay for the product initially and then seek reimbursement. While there is an upfront cost, the reimbursement typically more than offsets this, resulting in a significant profit margin for most customers. This profit margin is generally higher compared to other monitoring options such as service models or traditional Holter monitors.

Cardiac Insight provides several tools and programs to help you understand and maximize your reimbursement.

Can be worn up to 7 days, typically worn more than 1-2 days.

We offer a Holter Trade-In Program for healthcare providers who currently own their own Holter monitors. This program allows you to trade in your existing Holter devices for credit to purchase Cardea SOLO system.

To learn more and inquire about the trade-in program, please fill out the contact form. Our team will provide you with all the necessary details and assist you through the process.

Patients can continue their daily routine unless otherwise instructed by their healthcare provider. While being very simple to wear, Cardea SOLO requires your care and attention for a comfortable wear experience and the most useful information for their physician.

Cardea SOLO is water resistant, but does not support full submersion bathing or swimming. Avoid any activity that would cause excessive sweating.

If your Cardea SOLO monitor is found to be defective, we will replace it through our no-hassle RMA process. Please contact us to report the issue and initiate the replacement process.

We are committed to ensuring that you have reliable and functional devices for your patients.

Cardea SOLO has undergone rigorous testing and evaluation to ensure its reliability as an aid for clinicians in cardiac health assessment. Here are some key points:

• FDA Clearance: Cardea SOLO passed stringent testing and met all requirements before receiving FDA clearance, demonstrating its safety and effectiveness.

• Automated Process: The SOLO software automates processes such as noise filtering, report generation, and quality checks, ensuring consistency and accuracy in supporting clinical assessments. However, it is designed to assist clinicians, not replace them. The clinician remains responsible for ECG data collection, review, and interpretation.

• ANSI/AAMI EC-57:2012(R2020) Standard: SOLO adheres to this standard, which includes beat-by-beat and run-by-run analysis of clinically relevant records to detect significant events, ensuring compliance with industry standards for ECG devices.

• Proven Performance: With over 100,000 satisfied patients, Cardea SOLO has demonstrated its effectiveness and reliability as a tool that aids clinicians in providing high-quality care.

• References Available: We can provide references upon request to further assure you of the software’s trustworthiness and its role in enhancing, not replacing, clinical judgment.

Cardea SOLO does not require pre-authorization for Medicare and most major commercial insurance payers, including BCBS, United Healthcare, Humana, Aetna, and Cigna, according to their written medical policies. Pre-certification is required by Medicaid for all products, and a few exceptions such as BCBS Federal, Molina, and CareFirst may still require pre-authorization. Overall, not having to pre-authorize or pre-certify Cardea SOLO saves office staff time, money, and reduces frustration, allowing for a smoother workflow and quicker patient care.